| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 30 |
| 1 | APIXABAN | 17 |
| 2 | ASPIRIN | 17 |
| 3 | ASPIRIN 325 MG | 17 |
| 4 | ASPIRIN 81 MG | 17 |
| 5 | DABIGATRAN ETEXILATE | 15 |
| 6 | DABIGATRAN ETEXILATE MESYLATE | 13 |
| 7 | ERGOCALCIFEROL | 13 |
| 8 | RIVAROXABAN | 12 |
| 9 | INTERFERON BETA-1A | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN TOPICAL RECOMBINANT | 1 | 0.0147 |
| 1 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 2 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 3 | CYSTEAMINE BITARTRATE | 1 | 0.0010 |
| 4 | SEVOFLURANE | 8 | 0.0009 |
| 5 | DANTROLENE SODIUM | 1 | 0.0009 |
| 6 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 7 | HALOBETASOL PROPIONATE | 1 | 0.0007 |
| 8 | ARGATROBAN | 1 | 0.0007 |
| 9 | ROCURONIUM BROMIDE | 8 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 29 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 17 |
| 3 | Benzodiazepine [EPC] | 15 |
| 4 | Provitamin D2 Compound [EPC] | 13 |
| 5 | Interferon beta [EPC] | 12 |
| 6 | General Anesthetic [EPC] | 9 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 9 |
| 8 | Insulin Analog [EPC] | 6 |
| 9 | Interleukin-23 Antagonist [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 3 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 4 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 5 | General Anesthetic [EPC] | 9 | 0.0002 |
| 6 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 7 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |
| 8 | Factor Xa Inhibitor [EPC] | 29 | 0.0001 |
| 9 | Anti-anginal [EPC] | 1 | 0.0001 |